180
Participants
Start Date
January 10, 2018
Primary Completion Date
December 3, 2019
Study Completion Date
December 3, 2019
Rheosorbilact®
Administered intravenously (with speed 40-60 drip per minute) at a dose of 600 to 1,000 ml (10 to 15 ml/kg body weight per 24 hours) for 3 days.
Ringer lactate
Administered intravenously (with speed 40-60 drip per minute) at a dose of 1,000 to 2,500 ml (15 to 40 ml/kg body weight per 24 hours) for 3 days.
"Unimedi Adjara LLC", Batumi
Kutaisi Referral Hospital, Kutaisi
JSC EVEX/LTD Traumatology, Tbilisi
Institute of Ambulance, Chisinau
Municipal Clinical Hospital, Chisinau
Republican Clinical Hospital, Chisinau
Institute of General and Urgent Surgery of the National Academy of Medical Sciences of Ukraine, Kharkiv
Kyiv City Clinical Hospital No.4; National Medical University named after O.O. Bogomolets, Kyiv
"HSEE of Ukraine Ukrainian Medical Stomatological Academy; Poltava Central District Hospital", Poltava
Republic Centre of Ambulance, Tashkent
Yuria-Pharm
INDUSTRY